Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Boehringer Ingelheim
Mallinckrodt
Colorcon

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Olanzapine And Fluoxetine Hydrochloride, and what generic alternatives are available?

Olanzapine And Fluoxetine Hydrochloride is a drug marketed by Par Pharm, Sandoz, and Teva Pharms. and is included in four NDAs.

The generic ingredient in OLANZAPINE AND FLUOXETINE HYDROCHLORIDE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.

Summary for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Drug patent expirations by year for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Recent Clinical Trials for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts General HospitalEarly Phase 1
National Alliance on Mental IllnessN/A
University of New MexicoN/A

See all OLANZAPINE AND FLUOXETINE HYDROCHLORIDE clinical trials

Pharmacology for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

US Patents and Regulatory Information for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 077742-001 Nov 2, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 078901-001 Nov 16, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Par Pharm OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 077742-004 Nov 2, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 077528-001 Jun 19, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
Express Scripts
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.